Company
CPTx
- Biotech
- Location:
- Planegg, Germany
Description
CPTx develops in vivo CAR-T genetic medicines using an immune-silent ssDNA platform and non-viral lipid nanoparticle delivery to encode CARs with programmable payloads, enable repeat dosing, and support cancer cell therapy.
CPTx is located in the Munich ecosystem.
Related
NTrans TechnologiesNTrans Technologies develops a non-viral delivery platform for cell and gene therapies, providing modular delivery solutions for…
CutanosCutanos develops LC-TDS, a ligand-based delivery platform that uses langerin-specific glycomimetic ligands on lipid nanoparticles to…
TQ TherapeuticsTQ Therapeutics operates a CELLfinity platform that delivers in vivo cell and gene therapies using a proprietary EXiVO automated approach…
Prevision MedicinePrevision Medicine tests living cancer and healthy cells from a patient biopsy against 100+ drugs and combinations using a patented ex vivo…
Constructive BioConstructive Bio designs and manufactures new-to-nature proteins using expanded genetic code and programmable cellular manufacturing for…
- CeraVxCeraVx develops ceramic CeraMaps microneedle patches for intradermal delivery of vaccines and medicines, using biocompatible, inert…
TubulisTubulis generates antibody–drug conjugates and administers them with a proprietary platform that yields uniquely matched ADCs having…
CircioCircio develops circular RNA and immunotherapy medicines, including circVec AAV gene therapy work that uses circular RNA to enhance…
- EbenbuildEbenbuild develops lung digital twin technology that combines physics-based modeling with patient data to create virtual lung replicas for…